Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc., et al., C.A. No. 15-249 – LPS, July 5, 2016.

Stark, C. J. Claim construction opinion issues regarding one term from one patent. A Markman hearing took place on May 3, 2016. Defendants presented the testimony of an expert at the hearing, and plaintiff cross-examined.

The disputed technology relates to a transdermal product for the delivery of the hormone estradiol. The following term was considered:

  1. “coat weight selected from the group consisting of 12.5 mg/cm2 and 15 mg/cm2”